Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment is a research paper published in Frontiers in Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: K22 CA276632
National Institutes of Health
Grant: 1K22CA276632-01
Identification of resistance mechanisms to direct KRAS inhibition in pancreatic cancer
National Institutes of Health
FWCI
4.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals